Evidence map›Paper›PMID 28825602›Full record

ArticlePain2017

Role of neurturin in spontaneous itch and increased nonpeptidergic intraepidermal fiber density in a mouse model of psoriasis.

Kent Sakai, Kristen M Sanders, Marina R Youssef, Kevin M Yanushefski, Liselotte E Jensen, Gil Yosipovitch, Tasuku Akiyama

Open access · greenAbstract read
In one paragraph

Article in Pain, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Tenascin CNature communications · 2023
    Article
  3. Article
  4. Article
  5. Molecular and Cellular Mechanisms of Itch in Psoriasis.International journal of molecular sciences · 2020
    Review
  6. Review
  7. Mechanisms and Management of Itch in Dry Skin.Acta dermato-venereologica · 2020
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kent SakaiaDepartment of Dermatology and Cutaneous Surgery, Miami Itch Center, University of Miami, Miami, FL, USA bDepartment of Dermatology, Temple University, Philadelphia, PA, USA cDepartment of Microbiology and Immunology, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
Kristen M Sanders
Marina R Youssef
Kevin M Yanushefski
Liselotte E Jensen
Gil Yosipovitch
Tasuku Akiyama
University of Miami · USTemple University · US

Funding

Warmth enhancement of itch via TRPV4R00AR063228 · NIAMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI AKIYAMA, TASUKU · 2014 to 2016
$705k
Warmth enhancement of itch via TRPV4K99AR063228 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI AKIYAMA, TASUKU · 2013 to 2014
$176k
NIAMS NIH HHS K99 AR063228NIAMS NIH HHS R00 AR063228
6 · The paper itself

Abstract

Psoriasis is often accompanied by itch, but the mechanisms behind this symptom remain elusive. Dynamic changes in epidermal innervation have been observed under chronic itch conditions. Therefore, we investigated whether epidermal innervation is altered in the imiquimod-induced psoriasis mouse model, whether blockade of neurotrophic growth factor signaling can reduce these changes, and whether this system can impact psoriatic itch. Over the 7-day time course of imiquimod treatment, the density of epidermal nonpeptidergic nerves significantly increased, whereas the density of peptidergic nerves significantly decreased. The nonpeptidergic epidermal nerves expressed glial cell line-derived neurotrophic factor (GDNF) family receptor GFRα-1 and GFRα-2, the ligand-binding domains for GDNF and neurturin (NRTN). The NRTN mRNA expression was elevated in the skin of imiquimod-treated mice, whereas the GDNF mRNA expression was decreased. Treatment of imiquimod-challenged mice with an NRTN-neutralizing antibody significantly reduced nonpeptidergic nerve density as well as spontaneous scratching. These results indicate that NRTN contributes to an increase in the epidermal density of nonpeptidergic nerves in the imiquimod-induced psoriasis model, and this increase may be a factor in chronic itch for these mice. Therefore, inhibition of NRTN could be a potential treatment for chronic itch in psoriasis.

Indexed as

Adjuvants, ImmunologicAminoquinolinesAnimalsAntibodiesCalcitonin Gene-Related PeptideDisease Models, AnimalGene Expression RegulationGlial Cell Line-Derived Neurotrophic FactorGlial Cell Line-Derived Neurotrophic Factor ReceptorsImiquimodMaleMiceMice, Inbred C57BLNerve FibersNeurturinPruritusAdjuvants, ImmunologicAminoquinolinesAntibodiesCalcitonin Gene-Related PeptideGfra1 protein, mouseGfra2 protein, mouseGlial Cell Line-Derived Neurotrophic FactorGlial Cell Line-Derived Neurotrophic Factor ReceptorsImiquimodNeurturinReceptors, Purinergic P2X3RNA, Messenger

Identifiers

PMID28825602
PMCPMC5676563
OpenAlexW2741928261

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.